价格

CAR adjuvant

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL ADJUVANT THERAPIES
- EP 4531832 A4
  申请人: CYTOAGENTS INC优先权: 2022
  CN
  EP
  US
  WO
  4 件公开
- WO 2026117685 A1
  申请人: CYTOAGENTS INC优先权: 2024
  WO
CAR T-CELL ADJUVANT THERAPIES
EP 4251178 A2申请人: CYTOAGENTS INC优先权: 2020
EP
US
WO
4 件公开
COMPOSITIONS COMPRISING BACTERIAL STRAINS
CN 114025794 A申请人: 4D PHARMA RES LTD优先权: 2018
CN
Preparation and application of antibody with CD4 as target and CAR-T cells
CN 110452881 A申请人: FUJIAN GUKE BIOTECHNOLOGY CO LTD优先权: 2019
CN
Application of IFN-gamma (interferon-gamma) in preparation of anti-tumor adjuvant drug
CN 117731760 A申请人: WEST CHINA HOSPITAL SICHUAN UNIV优先权: 2020
CN
Tumor vaccine based on mRNA (messenger ribonucleic acid) as well as preparation and combined
CN 114588255 A申请人: SUZHOU XINLONG BIOMEDICAL SCIENCE AND TECH LIMITED COMPANY优先权: 2022
CN
METHOD FOR TREATING TUMOR USING IMMUNE CELL
US 20250114438 A1申请人: CARSGEN THERAPEUTICS CO LTD优先权: 2023
US
EPICHAPEROME INHIBITION TO IMPROVE T CELL RESPONSES
US 20250152702 A1申请人: GUZMAN MONICA L优先权: 2024
US
Immune tissue and cell targeting lipid nanoparticle as well as preparation method and application thereof
CN 121337975 A申请人: JINZHUOJI CHANGZHOU BIOLOGICAL TECH CO LTD优先权: 2025
CN
MRNA vaccine containing STING adjuvant and composition and application thereof
CN 121401406 A申请人: HANGZHOU INST OF MEDICAL CHINESE ACADEMY OF SCIENCES优先权: 2025
CN

药物

CAR adjuvant

专利

CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL ADJUVANT THERAPIES